Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile

por Lorusso, Domenica, Maltese, Giuseppa, Sabatucci, Ilaria, Cresta, Sara, Matteo, Cristina, Ceruti, Tommaso, D’Incalci, Maurizio, Zucchetti, Massimo, Raspagliesi, Francesco, Sonetto, Cristina, Sinno, Valentina, Ronzulli, Dominique, Giolitto, Serena, de Braud, Filippo
Publicado 2020

The Coup-TFII orphan nuclear receptor is an activator of the γ-globin gene

por Fugazza, Cristina, Barbarani, Gloria, Elangovan, Sudharshan, Marini, Maria Giuseppina, Giolitto, Serena, Font-Monclus, Isaura, Marongiu, Maria Franca, Manunza, Laura, Strouboulis, John, Cantu, Claudio, Gasparri, Fabio, Barabino, Silvia M.L., Nakamura, Yukio, Ottolenghi, Sergio, Moi, Paolo, Ronchi, Antonella Ellena
Publicado 2020